GlassScriptPhysician profile
Emily L Sammons
NPI 1780860395
$5,944.68
in general payments reported to CMS, 2019-2025
47 companies · $999 in 2025
The $999 reported for 2025 was more than what 90% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $694 · 2020: $412 · 2021: $926 · 2022: $896 · 2023: $895 · 2024: $1,122 · 2025: $999.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,015.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $955.79 | 2019-2024 | Lo Loestrin Fe, Ubrelvy |
| Evofem Biosciences, INC. | $423.26 | 2021-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $416.05 | 2021-2025 | |
| Astellas Pharma US INC | $291.34 | 2023-2025 | Veozah |
| Novo Nordisk INC | $270.49 | 2019-2024 | Wegovy |
| Sumitomo Pharma America, INC. | $266.28 | 2023-2025 | Myfembree |
| Shield Therapeutics INC | $256.56 | 2023-2025 | Accrufer |
| Therapeuticsmd, INC. | $238.48 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $183.96 | 2019-2025 | |
| Pfizer INC. | $181.98 | 2019-2024 | |
| Sage Therapeutics, LLC | $180.87 | 2024-2025 | Zurzuvae |
| Organon LLC | $165.61 | 2021-2025 | Nexplanon |
| Agile Therapeutics, INC. | $164.87 | 2021-2023 | Twirla |
| Hologic Sales and Service, LLC | $154.92 | 2021-2025 | Thinprep 2000 Processor, Aptima, Third Wave |
| Millicent US INC | $154.23 | 2025 | Femlyv, Intrarosa |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Sammons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.